The Broad Institute is a genomic medicine research center located in Cambridge, Massachusetts, United States. Although it is independently governed and supported as a 501(c)(3) nonprofit research ...
Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But using microscopy to do this at scale can be challenging, particularly when ...
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...
A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...
The Broad Institute of MIT and Harvard is partnering with Manifold to bring a unique life science research and development platform to investigators around the world. Healthcare data have become ...
Founded by MIT, Harvard, Harvard-affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...
A multi-modal transformer for cell type agnostic regulatory predictionsPublication: Cell Genomics , January 29, 20225Dana-Farber Cancer ...
The Trump administration's proposed freeze on federal funding raises concerns among universities, but Harvard and MIT are well-positioned to weather the storm. Their massive endowments ensure ...
A new study by investigators from Mass General Brigham, Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard found that eating greater quantities of red meat ...
Boston researchers found a link between ultra-processed meats and memory loss. Reporter Kay Lazar cuts through the fat. Regularly eating red meat has been linked with heart disease, diabetes, and ...
Researchers have discovered that about 5% of adult cancers rely on a gene called PELO to survive, offering a promising drug ...